Skip to main content
G3: Genes | Genomes | Genetics logoLink to G3: Genes | Genomes | Genetics
. 2022 Apr 22;12(6):jkac093. doi: 10.1093/g3journal/jkac093

Genetic analysis of DAF-18/PTEN missense mutants for the ability to maintain quiescence of the somatic gonad and germ line in Caenorhabditis elegans dauer larvae

Julia Wittes 1, Iva Greenwald 1,
Editor: S Lee
PMCID: PMC9157151  PMID: 35451467

Abstract

The mammalian tumor suppressor PTEN has well-established lipid phosphatase and protein phosphatase activities. DAF-18, the Caenorhabditis elegans ortholog of PTEN, has a high degree of conservation in the catalytic domain, and human PTEN complements a null allele of daf-18, suggesting conserved protein function. Insights gleaned from studies of mammalian PTEN have been applied to studies of DAF-18 in C. elegans, including predicted enzymatic properties of mutants. Here, we characterize DAF-18 missense mutants previously treated as selectively disrupting either protein or lipid phosphatase activity in genetic assays to connect distinct phenotypes to specific enzymatic activities of DAF-18/PTEN. We analyze the ability of these mutants to maintain quiescence of the somatic gonad and germ line in dauer larvae, a state of diapause during which development is suspended. We show that transgenes expressing either the putative lipid phosphatase-deficient or putative protein phosphatase-deficient form fail to complement a daf-18 null allele, and that the corresponding homozygous endogenous missense mutant alleles fail to maintain developmental quiescence. We also show that the endogenous daf-18 missense alleles fail to complement each other, suggesting that one or both of the missense forms are not activity-selective. Furthermore, homozygous daf-18 missense mutants have a more severe phenotype than a daf-18 null mutant, suggesting the presence of functionally compromised mutant DAF-18 is more deleterious than the absence of DAF-18. We discuss how these genetic properties complicate the interpretation of genetic assays to associate specific enzymatic activities with specific phenotypes.

Keywords: DAF-18, PTEN, dauer, Caenorhabditis elegans, quiescence, gonad

Introduction

PTEN is a dual-specificity phosphatase that regulates many different cellular processes, and abnormal PTEN activity is associated with cancer, autism, metabolic disease, and aging (reviewed in Ortega-Molina and Serrano 2013; Worby and Dixon 2014). PTEN has 2 enzymatic activities: a lipid phosphatase activity and a protein phosphatase activity (Myers et al. 1997, 1998; Furnari et al. 1998; Maehama and Dixon 1998; Stambolic et al. 1998). The Caenorhabditiselegans PTEN ortholog, DAF-18, also has both activities, and its phosphatase domain shares a high degree of sequence conservation with its human ortholog (Ogg and Ruvkun 1998; Gil et al. 1999; Rouault et al. 1999; Solari et al. 2005; Brisbin et al. 2009). Furthermore, transgenic human PTEN can rescue phenotypes caused by the absence of daf-18 in C. elegans (Solari et al. 2005; McDiarmid et al. 2018; Post et al. 2020), suggesting there is also substantial functional conservation. Thus, insights from biochemical and structural studies of mammalian PTEN have been applied to studies of DAF-18 in C. elegans.

These insights have included the extrapolation of the effect of missense mutations characterized in mammalian PTEN to DAF-18. In particular, missense mutations that preferentially disrupt lipid or protein phosphatase activity have offered the possibility of connecting specific mutant phenotypes caused by loss of daf-18 activity to specific enzymatic activities of DAF-18/PTEN. Thus, transgenes that express DAF-18 with missense mutations at equivalent amino acids to human PTEN have been assayed for the ability to rescue daf-18 null mutants for distinct phenotypes (Solari et al. 2005; Nakdimon et al. 2012; Zheng et al. 2018).

PTENG129E has little remaining lipid phosphatase activity, but retains significant protein phosphatase activity (Myers et al. 1997, 1998; Furnari et al. 1998; Ramaswamy et al. 1999; Han et al. 2000). The analogous mutant form, DAF-18(G174E), was unable to rescue a daf-18 null mutant in assays of lifespan or dauer entry (Solari et al. 2005), or to restore Q neuroblast quiescence during L1 arrest (Zheng et al. 2018), and these findings were interpreted as evidence that lipid phosphatase activity is essential to these processes. DAF-18(G174E) only partially restored inhibition of Ras pathway activity during vulval induction, interpreted as indicating that this interaction may be partially independent of lipid phosphatase activity (Nakdimon et al. 2012).

PTENY138L lacks protein phosphatase activity but appears to retain most lipid phosphatase activity, and is commonly used in mammalian studies; however, the affected residue is not conserved in C. elegans (Davidson et al. 2010; Tibarewal et al. 2012; Berglund et al. 2013). Instead, DAF-18(D137A), a mutant form equivalent to PTEND92A (Tamura et al. 1998), which binds to protein substrates but fails to release them, was treated as selectively protein phosphatase-deficient for the purposes of comparison with DAF-18(G174E) (Zheng et al. 2018). The ability of DAF-18(D137A) but not DAF-18(G174E) to restore Q neuroblast quiescence during L1 arrest was taken as support for the inference that lipid phosphatase activity was important, and that the different mutant forms preferentially affect different phosphatase activities (Zheng et al. 2018).

Here, we describe our analysis of these DAF-18 mutants for regulating quiescence of the somatic gonad and germ line in dauer diapause, a state of reversible developmental arrest that occurs in response to unfavorable environmental conditions (Murphy and Hu 2013; Karp 2018; Baugh and Hu 2020). In favorable conditions, C. elegans develops continuously through 4 larval stages (L1–L4) separated by molts, and reaches adulthood in about 3 days. However, if L1 larvae are grown under unfavorable conditions, they molt into second stage “L2d” larvae; if conditions do not improve, the L2d larvae molt into dauer larvae, which can endure for many months.

One consequence of dauer entry is the suspension of gonadogenesis. In dauer larvae, somatic gonad blast cells (SGBs) and germline stem cells (GSCs) are maintained in a state of quiescence (Masse et al. 2005; Narbonne and Roy 2006; Tenen and Greenwald 2019; Fig. 1a). Loss of daf-18 in the somatic gonad leads to loss of quiescence of both the SGBs and GSCs (Fig. 1b); expression of DAF-18 in the somatic gonad is able to rescue the progression defect of both populations of cells. It was proposed that DAF-18/PTEN in dauer larvae promotes the production or activity of one or more “pro-quiescence” signals in the somatic gonad that maintain quiescence of SGBs and GSCs (Tenen and Greenwald 2019).

Fig. 1.

Fig. 1.

Loss of somatic gonad and germline quiescence in daf-18(0) dauers. Gonadogenesis proceeds in 2 phases during continuous development. In the first phase, which ends in L2, the somatic gonad primordium forms; it contains 9 SGBs, 2 differentiated DTCs, and the differentiated AC. It also contains GSCs. Gonadogenesis appears to be suspended at approximately this point in dauer larvae. In the second phase, which begins in L3, the gonad arms extend longitudinally, the SGBs divide and ultimately give rise to descendants, including the uterine seam syncytial cell (utse) formed from the fusion of certain SGB descendants and the AC. The GSCs continue to proliferate; the first meioses begin in the L4 stage, giving rise to sperm. a) Schematic of daf-18(+) dauer gonadal anatomy. During dauer, the SGBs and GSCs enter a state of prolonged quiescence. b) Schematic of daf-18(0) dauer somatic gonadal anatomy. SGBs and GSCs do not maintain quiescence, and progress developmentally as in continuous development. They generally display morphological characteristics normally associated with the L4 stage of larval development, such as formation of the utse in the somatic gonad and an expanded germ line. In addition, some daf-18(0) dauers produce sperm (not diagrammed).

In this study, we wanted to gain insight into the identity of the hypothesized pro-quiescence signal(s) by asking if expression of DAF-18 mutant proteins presumed to be selectively defective in lipid [DAF-18(G174E)] or protein [DAF-18(D137A)] phosphatase activity differed in their ability to restore SGB and GSC quiescence in a daf-18 null mutant background. However, as described herein, our analysis of transgenes and endogenous alleles suggests that these mutations may not be sufficiently activity-selective to allow for such a distinction, with a particular concern about the specificity of DAF-18(D137A) for selective reduction of the protein phosphatase activity. A similar conclusion was reached in a companion study by Chen et al. (2022). Together, the 2 studies provide a cautionary tale against comparing these alleles for dissecting the contribution of different enzymatic activities of DAF-18 in C. elegans development. In addition, our analysis suggests that the presence of functionally compromised mutant DAF-18 is more deleterious than the absence of DAF-18, a finding with implications for other genetic experiments, such as interpreting results from rescue experiments that rely on multicopy array transgenes.

Materials and methods

Strains, alleles, and transgenes

Caenorhabditiselegans were maintained on NGM plates seeded with OP50 E. coli. Strain names and full genotypes used in this study are compiled in Supplementary Table 1. The temperature-sensitive dauer-constitutive mutation daf-7(e1372) (Riddle et al. 1981) was included in all strains. Strains were maintained at 15°C; embryos or L1 larvae were shifted to the restrictive temperature of 25°C to induce dauer entry.

The daf-18(ok480) allele contains a 956 bp deletion that removes most of exon 4 and all of exon 5, and ends in intron 5, and is generally considered to be a null allele (Kennedy et al. 2013; Liu et al. 2014; McDiarmid et al. 2018; Shi et al. 2020; Fry et al. 2021). Two additional alleles, daf-18{syb1615[daf-18(D137A)]} and daf-18{syb1618[daf-18(G174E)]}, were a gift from Ryan Baugh and Jingxian Chen (see accompanying paper by Chen et al. 2022). We note that daf-18(syb1615) and daf-18(syb1618) prevent dauer formation in a daf-7(+) background based on lack of SDS-resistant dauers on starved plates (Cassada and Russell 1975; Karp 2018). This dauer-defective phenotype was quantified by Chen et al. using suppression of dauer formation by daf-2(RNAi) (see Chen et al. 2022).

The strain VC4510 containing nog-1(gk5581[loxP + myo-2p::GFP::unc-54 3’UTR + rps-27p::neoR::unc-54 3’UTR + loxP]) IV (Au et al. 2019) was obtained from the CGC. The nog-1(gk5581) allele was used as a genetic balancer for daf-18 due to the close proximity of nog-1 and daf-18.

The following transgenes were used:

arIs51[cdh-3p::GFP] IV (Karp and Greenwald 2003) marks the anchor cell (AC) following its specification in L2 or L2d. In stage L4 and in daf-18(0) dauer larvae, arIs51 expression spreads to encompass multiple nuclei, reflecting formation of the uterine seam syncytial cell (utse) from the fusion of the AC to other uterine cells (Newman et al. 1995; Tenen and Greenwald 2019).

arSi40[mex-5p::2xmTagBFP2::his-11::tbb-2 3’UTR] I is an insertion in the ttTi4348 site on LGI, generated by Claire de la Cova (unpublished). This transgene is expressed in all germ cells, including GSCs, sperm, and oocytes.

Production of single copy DAF-18 rescue transgenes

Transgenes were assembled in the pWZ111 vector, which contains a self-excising cassette (SEC) (Dickinson et al. 2015) and homology arms for the ttTi4348 site on linkage group I (LGI); this vector was used to generate single-copy transgenes at a consistent site in the genome. To make pJSW56(ckb-3p::daf-18cDNA::gfp::unc-54 3’UTR), pWZ111 cut with NotI and AvrII was used as the plasmid backbone. ckb-3p::S::daf-18cDNA was amplified from pJSW37. “S” stands for synthetic intron; this cassette includes a Kozak sequence, and was included to enhance DAF-18 expression (Kozak 1986; Fire et al. 1990; Tenen and Greenwald 2019). The gfp::unc-54 3′UTR was amplified from pCT63; this gfp sequence is worm codon-optimized and includes 3 synthetic introns (Dickinson et al. 2015). pJSW56 was then assembled by Gibson cloning (HiFi reagent, NEB Inc., MA). To generate pJSW59[ckb-3p::daf-18(D137A)cDNA::gfp::unc-54 3′UTR], pJSW60[ckb-3p::daf-18(C169S)cDNA::gfp::unc-54 3′UTR], and pJSW61[ckb-3p::daf-18(G174E)cDNA::gfp::unc-54 3′UTR], pWZ111 cut with NotI and AvrII was used as the vector backbone, and mutations were introduced into pJSW56 by Gibson assembly using primers incorporating the desired mutations. To produce D137A, codon 137 (GAT) was mutated to GCT. To produce C169S, codon 169 (TGT) was mutated to TCA. To produce G174E, codon 174 (GGC) was mutated to GAA. All plasmids were verified by sequencing.

Transgenes were generated by microinjection into the germ line of wildtype Bristol N2 hermaphrodites by the approach of Pani and Goldstein (2018). Prior to injection, plasmids were purified with the Purelink miniprep kit (ThermoFisher). DAF-18 rescuing plasmids were injected at 50 ng/µl. Injection mixes included the plasmid pAP082, which expresses Cas9 in the germ line and an sgRNA targeting ttTi4348 on LG I (50 ng/µl). The coinjection markers pGH8 (10 ng/µl) and pCFJ90 (2.5 ng/µl), were also included in injection mixes. Worms bearing single copy insertions were selected using the dominant roller and hygromycin resistance genes present in the SEC. The SEC was then excised by heat shock. We note that ckb-3p::daf-18::gfp::unc-54 3′UTR expression could not be detected in the somatic gonad in dauer larvae. DAF-18::GFP was also not detectable in early L1, when ckb-3 promoter expression is strongest.

Single copy rescue transgenes generated for this study are:

arSi97[ckb-3p::daf-18::gfp::unc-54 3′ UTR], from pJSW56

arSi120[ckb-3p::daf-18(D137A)::gfp::unc-54 3′ UTR], from pJSW59

arSi108[ckb-3p::daf-18(C169S)::gfp::unc-54 3′ UTR], from pJSW60

arSi112[ckb-3p::daf-18(G174E)::gfp::unc-54 3′ UTR], from pJSW61

Preparation and imaging of dauer larvae

Partially synchronized populations of worms were obtained for imaging using either of 2 methods. For daf-18(0) rescue experiments, eggs were isolated by hypochlorite treatment (Stiernagle 2006) and shifted to 25°C to induce dauer formation. Animals were imaged at 72 h post-egg prep (PEP), at which point we estimate they have been in dauer for approximately 31–45 h. For all other experiments, embryos and L1s were isolated by a 24 h egg lay at 15°C and then shifted to 25°C. Dauers were imaged 48 h after the shift to 25°C, and we estimate worms have been in dauer for up to 29 h at this timepoint.

Dauers were isolated at the desired timepoint by treating worms with 1% SDS (Cassada and Russell 1975; Karp 2018) for 10 min. Dauers were then mounted on 4% agarose pads and immobilized with 2 µl of 10 mM levamisole in M9 and imaged. Only hermaphrodite dauer larvae were scored. Cross progeny were identified as such by the presence of the germline marker. Hermaphrodite dauers were identified by the presence of 2 gonad arms, as males do not have 2 arms. Furthermore, the germ line is segregated into the 2 gonad arms in the hermaphrodite dauer and clusters at the gonad posterior in the male. In 4/44 daf-18 trans-heterozygous dauers, the gonad morphology was sufficiently aberrant that they could not be confidently sexed based on these criteria and so they were excluded from further analysis.

For rescue experiments, imaging and scoring was performed using a Zeiss Axio Imager D1 microscope with a Zeiss AxioCam MRm camera and 40x Plan-Neo and 63x Plan-Apo objectives. All other imaging was performed using a Cell Observer SD spinning disc confocal microscope (Carl Zeiss) with a 40X, 1.4 NA objective. Five micrometers Z-slices were acquired in all Z-planes containing detectable germ cell nuclei, marked by arSi40[mex-5p::2xmTagBFP2::his-11::tbb-2 3′UTR]. Confocal images were acquired with a Hamamatsu Orca flash 4.0 LT+ CMOS camera.

Quantifying somatic gonad progression using arIs51

Dauer larvae with detectable arIs51 expression in a swath of multiple cells were scored as “progressed” (Tenen and Greenwald 2019), and dauers with expression in 1 cell (or, very occasionally, in 0 cells or 2 cells both appearing to be ACs) were scored as “not progressed”. The percentage of animals displaying evidence of somatic gonad progression for a given genotype was computed, and two-tailed Fisher’s exact tests were performed using R to judge whether the penetrance of somatic gonad progression differed among genotypes. Plots were made with GraphPad Prism 9 software.

Quantifying germline progression using arSi40

GSCs were manually counted in ImageJ. Sperm were not included in the GSC count. For some animals, GSCs could not be accurately counted because the arSi40 marker was too dim, because of movement during imaging, or because of issues with mounting, such as the presence of a bubble close to a worm. Brown-Forsythe and Welch ANOVA tests with Dunnett’s T3 test for multiple comparisons were used to analyze GSC count data; plots were generated in Prism.

Results

At hatching, the C. elegans gonad consists of 2 somatic gonad progenitor cells, Z1 and Z4, and 2 germline progenitor cells, Z2 and Z3. During the first phase of gonadogenesis, which is completed by the end of the L2 stage, Z1 and Z4 generate a 12-cell somatic gonad primordium, which includes 9 SGBs and 3 terminally differentiated cells: the 2 distal tip cells (DTCs) and the AC (Kimble and Hirsh 1979). The second phase of gonadogenesis, which occurs in the L3 and L4 stages during continuous development, is associated with landmark developmental events, including the production of a multinucleate syncytium called the utse, generated by fusion of the AC and descendants of the ventral uterine precursor cells (VUs) in the L4 stage (Kimble 1981; Newman et al. 1995), and the extension and reflexion of the gonad arms led by the DTCs (Kimble 1981; Kimble and White 1981). The germline progenitors Z2 and Z3 undergo mitosis in L1 and generate the germline stem cells (GSCs) (Hubbard and Schedl 2019). The DTCs regulate division of the GSCs and the timing of meiotic entry; the GSCs proliferate mitotically until the L4 stage, when the GSCs furthest from the DTCs enter meiosis and produce sperm. In adult hermaphrodites, the GSCs produce gametes that differentiate as oocytes.

daf-18 missense mutants lack quiescence-promoting activity in the daf-18(0) dauer gonad

The decision to enter and exit dauer involves integrating information about population density, temperature, and food availability. Food availability and population density are sensed by the insulin/IGF-1 signaling (IIS) and transforming growth factor Beta (TGF-β) signaling pathways (reviewed in Murphy and Hu 2013; Baugh and Hu 2020). In the presence of food, IIS is active, leading to activation of PI3K and the production of PIP3 from PIP2; in the absence of food, when IIS is inactive, low PIP3 levels favor dauer entry. DAF-18/PTEN opposes IIS activity by dephosphorylating PIP3. Thus, in mutants lacking DAF-18/PTEN, high PIP3 levels are able to accumulate even when the food signal is absent, opposing dauer entry, and daf-18 single mutants are dauer-defective. However, dauers lacking daf-18 can be made by compromising daf-7/TGF-β signaling, a parallel input into the decision to enter dauer (Vowels and Thomas 1992; Larsen et al. 1995; Narbonne and Roy 2006). daf-7(e1372ts) produces obligate dauer entry in young worms (embryos or L1s) raised at 25°C, and all daf-18(+) and daf-18 mutant dauers in this study also carry the daf-7(e1372) allele.

Dauer diapause induced by unfavorable environmental conditions or by a daf-7 mutation is associated with the suspension of gonadogenesis after the first phase and the cessation of GSC mitosis (Fig. 1a). In daf-18(+) dauer larvae, the SGBs and germline stem cells (GSCs) are quiescent; in daf-18(0) dauers, they are not, such that the SGBs continue to progress developmentally and generate differentiated descendants, and the GSCs proliferate mitotically (Narbonne and Roy 2006; Tenen and Greenwald 2019; Fig. 1b). A single-copy insertion transgene that expresses DAF-18(+) in the somatic gonad cells under the control of the ckb-3p regulatory sequence (Kroetz and Zarkower 2015) is sufficient to restore quiescence to both SGBs and GSCs (Tenen and Greenwald 2019).

As a first step toward identifying the hypothesized pro-quiescence signal or signals originating in the somatic gonad and acting on the SGBs and GSCs (Tenen and Greenwald 2019), we wanted to identify the relevant phosphatase activity or activities of DAF-18 for maintaining SGB and GSC quiescence using missense mutations reported to be selectively deficient in the protein phosphatase (D137A) or lipid phosphatase (G147E) activity of DAF-18, or in both phosphatase activities (C169S) (see Introduction and Fig. 2). We generated single-copy insertion transgenes expressing DAF-18 missense mutant proteins tagged with GFP at the carboxy terminus under control of the somatic gonad-specific ckb-3 promoter (Kroetz and Zarkower 2015) at a common site on chromosome I to provide a uniform genomic context (Materials and Methods). daf-18(0) dauer larvae carrying these transgenes were examined 72 h post egg prep (Fig. 2b), at which point we estimate they have been in dauer diapause for 31–45 h (Tenen and Greenwald 2019).

Fig. 2.

Fig. 2.

Developmental quiescence of the daf-18(0) dauer gonad is not restored by rescue constructs with mutant daf-18 alleles. a) Partial alignment of human PTEN and C. elegans DAF-18. Residues referenced in this study are indicated. (*) Identical, (:) conservative, (.) semi-conservative. A complete sequence alignment of DAF-18 and human PTEN can be found in McDiarmid et al. (2018). In addition to the DAF-18(G174E) and DAF-18(D137A) mutants, we also assayed DAF-18(C169S), which is thought to be equivalent to PTENC124S and to lack both phosphatase activities (Barford et al. 1994; Myers et al. 1997, 1998; Maehama and Dixon 1998; Lee et al. 1999); it may also have “substrate-trapping” properties i.e. binding to but not releasing substrates (Flint et al. 1997; Myers et al. 1997, 1998; Maehama and Dixon 1998; Ramaswamy et al. 1999; Qi et al. 2020). b) Quantification of somatic gonad progression in daf-18(0) dauers expressing single-copy DAF-18 transgenes, scored with arIs51[cdh-3p::gfp]. Expression of wildtype DAF-18 in the somatic gonad fully restored somatic gonad quiescence. None of the 3 DAF-18 mutants significantly rescued the progression defect. ****P < 0.0001 by two-tailed Fisher’s exact test, ns = no significant difference. Full genotypes can be found in Supplementary Table 1.

To assess the maintenance of SGB quiescence, we used the fluorescent reporter arIs51[cdh-3p::gfp] (Karp and Greenwald 2003). During continuous development, GFP fluorescence is restricted to the AC in the L3 stage, but in the L4 stage, expression expands throughout the utse syncytium formed by fusion of descendants of 3 SGBs (the ventral uterine precursor cells) and the AC (Newman et al. 1995). In daf-18(+) dauers, arIs51 expression in the gonad is restricted to the AC, but in most daf-18(0) dauers, expression expands to a utse-like structure (Fig. 1), reflecting developmental progression to the equivalent of the L4 stage (Tenen and Greenwald 2019). Expression of transgenic DAF-18(+)::GFP resulted in full rescue of the somatic gonad progression defect (Fig. 2b), although fluorescence from DAF-18(+)::GFP was not visible in any somatic gonad cells. None of the daf-18::gfp mutant transgenes (Fig. 2a) had significant rescuing activity (Fig. 2b). Although we did not quantify GSCs in this experiment, the width of the gonad arm appeared to be expanded, which is indicative of GSC progression in dauer larvae (Hong et al. 1998; Narbonne and Roy 2006; Tenen and Greenwald 2019).

The inability of the D137A and G174E mutants to restore SGB quiescence may indicate that both the lipid and protein phosphatase activities are required to maintain quiescence. However, it also seemed possible that the assumptions made about these alleles are not correct, and that they are not as selective as presumed. Using endogenous alleles with the same amino acid changes, the question of selectivity then became the focus of our work.

daf-18(D137A) and daf-18(G174E) mutants lose quiescence in the somatic gonad and germ line

We next examined the phenotypes associated with the endogenous mutations daf-18(syb1615), hereafter denoted as daf-18(D137A), and daf-18(syb1618), denoted as daf-18(G174E), kindly provided by Jingxian Chen and Ryan Baugh (see Chen et al. 2022), using daf-7(e1372) to drive dauer formation as described above. daf-18(D137A) and daf-18(G174E) dauers, like daf-18(0) dauers, displayed an enlarged gonad, which was readily visible by DIC microscopy (Fig. 3). Furthermore, somatic gonad progression to the formation of the utse was detected in a significantly higher fraction of daf-18(D137A) and daf-18(G174E) dauers (≥92%) than daf-18(0) dauers (63%) (Fig. 4b).

Fig. 3.

Fig. 3.

Representative images of the anterior gonad arm for genotypes analyzed in Fig. 4. Full genotypes can be found in Supplementary Table 1. arIs51[cdh-3p::gfp] is restricted to the AC (closed arrowhead) in the quiescent gonad of daf-18(+) dauers. Expanded GFP expression reflects developmental progression of the somatic gonad and formation of a utse-like structure (open arrowhead) in daf-18 mutant dauers. For each genotype, the anterior arm is featured and the outline of the gonad is delimited by a white dotted line. Germ cell nuclei are marked with arSi40[mex-5p::bfp::h2b]. Sperm were present in the proximal gonad of all daf-18 larvae shown in this figure. Sperm nuclei are characteristically more compact than GSC nuclei; see grayscale panel depicting sperm and GSC nuclei (marked by arSi40) in the proximal gonad of a daf-18(0) dauer larva. Scale bars are 10 µm.

Fig. 4.

Fig. 4.

Characterization of somatic gonad and germline progression for endogenous daf-18 alleles. All genotypes include daf-7(e1372) to drive dauer formation and the markers arIs51[cdh-3p::gfp] and arSi40[mex-5p::bfp::h2b]. Full genotypes can be found in Supplementary Table 1. Only statistically significant differences are shown. a) Mating scheme for generating daf-18 trans-heterozygous dauer larvae. See Materials and Methods for marker details. b) Somatic gonad progression. All daf-18 homozygous mutant genotypes displayed significant developmental progression compared to daf-18(+) dauers. Progression occurred with a higher penetrance in daf-18(G174E) and daf-18(D137A) dauers than in daf-18(0) dauers. ****P < 0.0001, *P < 0.05, two-tailed Fisher’s exact test. c) Germline progression. All daf-18 homozygous mutant genotypes had significantly more GSCs compared to daf-18(+) dauers. daf-18(D137A), daf-18(G174E) and daf-18(D137A/G174E) dauers have significantly more GSCs than daf-18(0) or daf-18(+) dauers. For each genotype, in-graph numbers are mean GSC numbers. Error bars represent 95% confidence intervals. P-values were computed using Brown-Forsythe and Welch ANOVAs with Dunnett’s T3 test for multiple comparisons. ****P < 0.0001, ***P < 0.001. Sperm were present in some daf-18 homozygous and trans-heterozygous dauers, which reflects L4-like germline progression. d) Somatic gonad progression was not observed in daf-18/+ heterozygous dauers. Somatic gonad progression was assessed using arIs51[cdh-3p::gfp]. e) Weak semi-dominant germline progression was observed in daf-18(D137A/+) and daf-18(G174E/+) heterozygous dauers. In-graph numbers, error bars, and statistical testing are as in c. The small effect was only apparent by counting the number of GSCs, as the overall anatomy was indistinguishable from daf-18(+) dauers; sperm were never observed. **P < 0.01, ***P < 0.001.

We also quantified germline progression using the nuclear-localized germline marker arSi40[mex-5p::2xmTagBFP2::his-11::tbb-2 3’UTR], which marks GSCs and differentiated germ cells. This analysis revealed that daf-18(G174E) and daf-18(D137A) dauers have significantly more GSCs than daf-18(+) and daf-18(0) homozygotes (Fig. 4c). Sperm production normally begins in the L4 stage, and sperm were never detected in daf-18(+) dauers (n = 0/16); however, sperm were observed in daf-18(0) (n = 8/24; 33%), daf-18(D137A) (n = 11/27; 41%) and daf-18(G174E) (n = 10/24; 42%) dauers (see Fig. 3). The presence of sperm in daf-18 dauers has not been reported previously, and their presence suggests that the germ line, like the somatic gonad, progresses to an L4-equivalent stage in daf-18 dauers.

The developmental progression observed for the endogenous daf-18(G174E) and daf-18(D137A) alleles is consistent with the inability of the equivalent mutant forms to rescue developmental progression in daf-18(0) dauers when expressed from transgenes, as described above. Importantly, the higher penetrance of somatic gonad defects and more severe germline defects in daf-18(G174E) and daf-18(D137A) dauers than daf-18(0) suggests that the presence of functionally compromised mutant DAF-18 is more deleterious than the absence of DAF-18.

daf-18(D137A) and daf-18(G174E) alleles fail to complement

If the daf-18(D137A) and daf-18(G174E) alleles were truly selective for different phosphatase activities, we reasoned that they would display intragenic complementation. As a prelude to performing the complementation test, we assessed the daf-18 null allele for haploinsufficiency and the missense alleles for dominance, properties that would preclude complementation testing.

To assess haploinsufficiency, we examined daf-18(0/+) dauers, and found that the arIs51 marker was always restricted to the AC (Fig. 4d) and the gonads of heterozygous animals were comparable in size and shape to daf-18(+/+) dauers. There was also no significant difference in germ cell number between daf-18(0/+) dauers and daf-18(+/+) dauers (Fig. 4e). These results indicate that daf-18 is not haploinsufficient.

To assess the dominance of missense mutations, we examined daf-18 missense mutant heterozygous dauers. The somatic gonad resembled daf-18(+/+) dauers, indicating that these alleles are recessive for this phenotype; similarly, the gonad arms were not overtly expanded and sperm were not seen, consistent with the mutations being recessive for loss of germline quiescence and developmental progression. However, the number of GSCs in the daf-18(D137A/+) and daf-18(G174E/+) heterozygotes is slightly greater than in control daf-18(+/+) dauers (Fig. 4e), suggesting that there may be a weak dominant-negative effect of these missense mutations, which may occur during or prior to dauer entry (Narbonne and Roy 2006), even though overt developmental progression is halted in dauer (compare Fig. 4, c and e).

We therefore proceeded with the complementation test, and found that daf-18(D137A/G174E) trans-heterozygotes did not display complementation with respect to somatic gonad (Fig. 4b) or GSC (Fig. 4c) quiescence. Furthermore, the number of GSCs in daf-18(G174E/D137A) trans-heterozygous dauers and the penetrance of somatic gonad progression (81%) is not statistically different from that of daf-18(G174E) and daf-18(D137A) single mutants, and sperm are present in trans-heterozygous dauers (n = 6/16; 38%). These results suggest that the daf-18(D137A) and daf-18(G174E) alleles do not display distinct functional separation of lipid and protein phosphatase activities. We cannot distinguish from these data whether one or both alleles are not sufficiently selective to allow for discrimination of different activities genetically, and we describe further considerations below.

Discussion

In this study, we investigated the ability of DAF-18 missense mutant proteins that had been assumed to selectively lack either protein or lipid phosphatase activities to maintain developmental quiescence of the somatic gonad and/or germ line in dauer larvae. We found that transgenes encoding the DAF-18(D137A) putative protein phosphatase-lacking and DAF-18(G174E) putative lipid phosphatase-lacking forms, as well as the corresponding endogenous missense alleles of daf-18, appear unable to maintain quiescence of the somatic gonad or germ line of dauer larvae. A similar finding was made by Chen et al. (see accompanying paper) in their studies of the ability of these alleles to promote starvation resistance during L1 arrest.

Taken at face value, our results for the single mutants imply that both the lipid and protein phosphatase activities of DAF-18 are required for maintaining developmental quiescence in dauer larvae. However, we also analyzed the trans-heterozygote daf-18(D137A)/daf-18(G174E) and found that the alleles failed to complement for maintaining quiescence of the somatic gonad and germ line in dauer larvae. If both alleles were truly selective, and if both phosphatase activities were indeed required, we would have expected them to complement each other. Chen et al. have found that daf-18(D137A) and daf-18(G174E) also fail to complement for promoting starvation resistance during L1 arrest. Thus, we believe that one or both alleles are not sufficiently selective to allow for discrimination of different activities genetically, and that our findings offer a cautionary tale for their use in associating a specific mutant phenotype caused by loss of daf-18 activity to a specific enzymatic activity of DAF-18/PTEN.

Revisiting the mammalian literature that directed the mutations used to generate these alleles, there is considerable evidence that PTENG129E selectively lacks lipid phosphatase activity relative to protein phosphatase activity (Myers et al. 1997, 1998; Furnari et al. 1998; Ramaswamy et al. 1999; Han et al. 2000), whereas there is less support for the contention that PTEND92A selectively lacks protein phosphatase activity. Indeed, there is evidence that PTEND92A has reduced lipid phosphatase activity (Furnari et al. 1998; Lee et al. 1999; Ramaswamy et al. 1999; Xiao et al. 2007; Rodríguez-Escudero et al. 2011), so DAF-18(D137A) may be deficient in both phosphatase activities, accounting for the failure of complementation in trans-heterozygotes even if DAF-18(G174E) does selectively lack lipid phosphatase activity.

Our finding that homozygous daf-18 G174E and D137A mutant dauers have more GSC proliferation than homozygous daf-18(0) dauers indicates that some forms of DAF-18 are more deleterious than its complete absence. Additional complexities in using these alleles for genetic analysis can be inferred: for instance, they may provide misleading results in rescue assays, particularly if conventional multicopy arrays are used and a negative result is obtained. Given the sensitivity and ease of quantification of GSC proliferation in dauer larvae, it may be a useful assay for exploring the deleterious effects of other mutations in DAF-18 and human PTEN, given the demonstrated ability to human PTEN to substitute for DAF-18 (Solari et al. 2005; McDiarmid et al. 2018; Post et al. 2020).

Data availability

The data underlying this article are available in the article and in its Supplementary material online. All strains, plasmids, transgenes, and sequences generated for this study are available upon request.

Supplemental material is available at G3 online.

Supplementary Material

jkac093_Supplementary_Data

Acknowledgments

The authors thank Ryan Baugh and Jingxian Chen for generously providing the endogenous daf-18(syb1618) and daf-18(syb1615) alleles, and for discussion of results and interpretations. They thank Michelle Attner, Katherine Luo, Claudia Tenen, and Catherine O’Keeffe for helpful discussions during the course of this project, and Ryan Baugh and Catherine O'Keeffe for comments on this manuscript. They are grateful to Claire de la Cova for generating the arSi40 germline marker and Claudia Tenen for pCT63. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).

Funding

This work was supported by grants R35GM131746 from the National Institute of General Medical Sciences (to IG), F32GM140732 (to JW), and training grant 5T32DK007328. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).

Conflict of interest

None declared.

Literature cited

  1. Au V, Li-Leger E, Raymant G, Flibotte S, Chen G, Martin K, Fernando L, Doell C, Rosell FI, Wang S, et al. CRISPR/Cas9 methodology for the generation of knockout deletions in Caenorhabditis elegans. G3 (Bethesda). 2019;9(1):135–144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barford D, Flint AJ, Tonks NK.. Crystal structure of human protein tyrosine phosphatase 1B. Science. 1994;263(5152):1397–1404. [PubMed] [Google Scholar]
  3. Baugh LR, Hu PJ.. Starvation responses throughout the Caenorhabditis elegans life cycle. Genetics. 2020;216(4):837–878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berglund FM, Weerasinghe NR, Davidson L, Lim JC, Eickholt BJ, Leslie NR.. Disruption of epithelial architecture caused by loss of PTEN or by oncogenic mutant p110α/PIK3CA but not by HER2 or mutant AKT1. Oncogene. 2013;32(37):4417–4426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brisbin S, Liu J, Boudreau J, Peng J, Evangelista M, Chin-Sang I.. A role for C. elegans Eph RTK signaling in PTEN regulation. Dev Cell. 2009;17(4):459–469. [DOI] [PubMed] [Google Scholar]
  6. Cassada RC, Russell RL.. The dauerlarva, a post-embryonic developmental variant of the nematode Caenorhabditis elegans. Dev Biol. 1975;46(2):326–342. [DOI] [PubMed] [Google Scholar]
  7. Chen J, Russell LY, Powell ME, Jordan JM, Baugh LR.. Genetic analysis of daf-18/PTEN missense mutants for starvation resistance and developmental regulation during Caenorhabditis elegans L1 arrest. G3 (Bethesda). 2022;jkac092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davidson L, Maccario H, Perera NM, Yang X, Spinelli L, Tibarewal P, Glancy B, Gray A, Weijer CJ, Downes CP, et al. Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN. Oncogene. 2010;29(5):687–697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dickinson DJ, Pani AM, Heppert JK, Higgins CD, Goldstein B.. Streamlined genome engineering with a self-excising drug selection cassette. Genetics. 2015;200(4):1035–1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fire A, Harrison SW, Dixon D.. A modular set of lacZ fusion vectors for studying gene expression in Caenorhabditis elegans. Gene. 1990;93(2):189–198. [DOI] [PubMed] [Google Scholar]
  11. Flint AJ, Tiganis T, Barford D, Tonks NK.. Development of ‘“substrate-trapping”’ mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci USA. 1997;94(5):1680–1685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fry AL, Webster AK, Burnett J, Chitrakar R, Baugh LR, Hubbard EJA.. DAF-18/PTEN inhibits germline zygotic gene activation during primordial germ cell quiescence. PLoS Genet. 2021;17(7):e1009650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Furnari FB, Huang H-JS, Cavenee WK.. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 1998;58(22):5002–5008. [PubMed] [Google Scholar]
  14. Gil EB, Malone Link E, Liu LX, Johnson CD, Lees JA.. Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene. Proc Natl Acad Sci USA. 1999;96(6):2925–2930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Han SY, Kato H, Kato S, Suzuki T, Shibata H, Ishii S, Shiiba K, Matsuno S, Kanamaru R, Ishioka C, et al. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay. Cancer Res. 2000;60(12):3147–3151. [PubMed] [Google Scholar]
  16. Hong Y, Roy R, Ambros V.. Developmental regulation of a cyclin-dependent kinase inhibitor controls postembryonic cell cycle progression in Caenorhabditis elegans. Development. 1998;125(18):3585–3597. [DOI] [PubMed] [Google Scholar]
  17. Hubbard EJA, Schedl T.. Biology of the Caenorhabditis elegans germline stem cell system. Genetics. 2019;213(4):1145–1188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Karp X. Working with dauer larvae. WormBook. 2018;2018:1.doi/10.1895/wormbook.1.180.1. http://www.wormbook.org. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Karp X, Greenwald I.. Post-transcriptional regulation of the E/Daughterless ortholog HLH-2, negative feedback, and birth order bias during the AC/VU decision in C. elegans. Genes Dev. 2003;17(24):3100–3111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kennedy LM, Pham SCDL, Grishok A.. Nonautonomous regulation of neuronal migration by insulin signaling, DAF-16/FOXO, and PAK-1. Cell Rep. 2013;4(5):996–1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kimble J. Alterations in cell lineage following laser ablation of cells in the somatic gonad of Caenorhabditis elegans. Dev Biol. 1981;87(2):286–300. [DOI] [PubMed] [Google Scholar]
  22. Kimble J, Hirsh D.. The postembryonic cell lineages of the hermaphrodite and male gonads in Caenorhabditis elegans. Dev Biol. 1979;70(2):396–417. [DOI] [PubMed] [Google Scholar]
  23. Kimble JE, White JG.. On the control of germ cell development in Caenorhabditis elegans. Dev Biol. 1981;81(2):208–219. [DOI] [PubMed] [Google Scholar]
  24. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 1986;44(2):283–292. [DOI] [PubMed] [Google Scholar]
  25. Kroetz MB, Zarkower D.. Cell-specific mRNA profiling of the Caenorhabditis elegans somatic gonadal precursor cells identifies suites of sex-biased and gonad-enriched transcripts. G3 (Bethesda). 2015;5(12):2831–2841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Larsen PL, Albert PS, Riddle DL.. Genes that regulate both development and longevity in Caenorhabditis elegans. Genetics. 1995;139(4):1567–1583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lee J-O, Yang H, Georgescu M-M, Di Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP.. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell. 1999;99(3):323–334. [DOI] [PubMed] [Google Scholar]
  28. Liu J, Visser-Grieve S, Boudreau J, Yeung B, Lo S, Chamberlain G, Yu F, Sun T, Papanicolaou T, Lam A, et al. Insulin activates the insulin receptor to downregulate the PTEN tumour suppressor. Oncogene. 2014;33(29):3878–3885. [DOI] [PubMed] [Google Scholar]
  29. Maehama T, Dixon JE.. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998;273(22):13375–13378. [DOI] [PubMed] [Google Scholar]
  30. Masse I, Molin L, Billaud M, Solari F.. Lifespan and dauer regulation by tissue-specific activities of Caenorhabditis elegans DAF-18. Dev Biol. 2005;286(1):91–101. [DOI] [PubMed] [Google Scholar]
  31. McDiarmid TA, Au V, Loewen AD, Liang J, Mizumoto K, Moerman DG, Rankin CH. CRISPR-Cas9 human gene replacement and phenomic characterization in Caenorhabditis elegans to understand the functional conservation of human genes and decipher variants of uncertain significance. Dis Model Mech. 2018;11:dmm036517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Murphy CT, Hu JP.. Insulin/insulin-like growth factor signaling in C. elegans. In: The C. elegans Research Community WormBook, editor. WormBook. 2013. p. 1–43. doi/10.1895/wormbook.1.164.1. http://www.wormbook.org [accessed 2022 Apr 25]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK.. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA. 1998;95(23):13513–13518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, Tonks NK.. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA. 1997;94(17):9052–9057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Nakdimon I, Walser M, Fröhli E, Hajnal A.. PTEN negatively regulates MAPK signaling during Caenorhabditis elegans vulval development. PLoS Genet. 2012;8(8):e1002881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Narbonne P, Roy R.. Inhibition of germline proliferation during C. elegans dauer development requires PTEN, LKB1 and AMPK signalling. Development. 2006;133(4):611–619. [DOI] [PubMed] [Google Scholar]
  37. Newman AP, White JG, Sternberg PW.. The Caenorhabditis elegans lin-12 gene mediates induction of ventral uterine specialization by the anchor cell. Development. 1995;121(2):263–271. [DOI] [PubMed] [Google Scholar]
  38. Ogg S, Ruvkun G.. The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol Cell. 1998;2(6):887–893. [DOI] [PubMed] [Google Scholar]
  39. Ortega-Molina A, Serrano M.. PTEN in cancer, metabolism, and aging. Trends Endocrinol Metab. 2013;24(4):184–189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Pani AM, Goldstein B.. Direct visualization of a native Wnt in vivo reveals that a long-range Wnt gradient forms by extracellular dispersal. eLife. 2018;7:e38325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Post KL, Belmadani M, Ganguly P, Meili F, Dingwall R, McDiarmid TA, Meyers WM, Herrington C, Young BP, Callaghan DB, et al. Multi-model functionalization of disease-associated PTEN missense mutations identifies multiple molecular mechanisms underlying protein dysfunction. Nat Commun. 2020;11(1):2073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Qi Y, Liu J, Chao J, Greer PA, Li S.. PTEN dephosphorylates Abi1 to promote epithelial morphogenesis. J Cell Biol. 2020;219:e201910041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM, Sellers WR.. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA. 1999;96(5):2110–2115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Riddle DL, Swanson MM, Albert PS.. Interacting genes in nematode dauer larva formation. Nature. 1981;290(5808):668–671. [DOI] [PubMed] [Google Scholar]
  45. Rodríguez-Escudero I, Oliver MD, Andrés-Pons A, Molina M, Cid VJ, Pulido R.. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes. Hum Mol Genet. 2011;20(21):4132–4142. [DOI] [PubMed] [Google Scholar]
  46. Rouault JP, Kuwabara PE, Sinilnikova OM, Duret L, Thierry-Mieg D, Billaud M.. Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN. Curr Biol. 1999;9(6):329–332. [DOI] [PubMed] [Google Scholar]
  47. Shi D, Xia X, Cui A, Xiong Z, Yan Y, Luo J, Chen G, Zeng Y, Cai D, Hou L, et al. The precursor of PI(3,4,5)P3 alleviates aging by activating daf-18(Pten) and independent of daf-16. Nat Commun. 2020;11(1):4496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Solari F, Bourbon-Piffaut A, Masse I, Payrastre B, Chan AM-L, Billaud M.. The human tumour suppressor PTEN regulates longevity and dauer formation in Caenorhabditis elegans. Oncogene. 2005;24(1):20–27. [DOI] [PubMed] [Google Scholar]
  49. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998;95(1):29–39. [DOI] [PubMed] [Google Scholar]
  50. Stiernagle T. Maintenance of C. elegans. In: The C. elegans Research Community WormBook, editor. WormBook. 2006; doi/10.1895/wormbook.1.101.1. http://www.wormbook.org [accessed 2022 Apr 25]. [Google Scholar]
  51. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM.. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science. 1998;280(5369):1614–1617. [DOI] [PubMed] [Google Scholar]
  52. Tenen CC, Greenwald I.. Cell non-autonomous function of daf-18/PTEN in the somatic gonad coordinates somatic gonad and germline development in C. elegans dauer larvae. Curr Biol. 2019;29(6):1064–1072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Tibarewal P, Zilidis G, Spinelli L, Schurch N, Maccario H, Gray A, Perera NM, Davidson L, Barton GJ, Leslie NR.. PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity. Sci Signal. 2012;5(213):ra18. [DOI] [PubMed] [Google Scholar]
  54. Vowels JJ, Thomas JH.. Genetic analysis of chemosensory control of dauer formation in Caenorhabditis elegans. Genetics. 1992;130(1):105–123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Worby CA, Dixon JE.. Pten. Annu Rev Biochem. 2014;83:641–669. [DOI] [PubMed] [Google Scholar]
  56. Xiao Y, Yeong Chit Chia J, Gajewski JE, Sio Seng Lio D, Mulhern TD, Zhu H-J, Nandurkar H, Cheng H-C.. PTEN catalysis of phospholipid dephosphorylation reaction follows a two-step mechanism in which the conserved aspartate-92 does not function as the general acid — Mechanistic analysis of a familial Cowden disease-associated PTEN mutation. Cell Signal. 2007;19(7):1434–1445. [DOI] [PubMed] [Google Scholar]
  57. Zheng S, Qu Z, Zanetti M, Lam B, Chin-Sang I.. C. elegans PTEN and AMPK block neuroblast divisions by inhibiting a BMP-insulin-PP2A-MAPK pathway. Development. 2018;145(23):dev166876. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

jkac093_Supplementary_Data

Data Availability Statement

The data underlying this article are available in the article and in its Supplementary material online. All strains, plasmids, transgenes, and sequences generated for this study are available upon request.

Supplemental material is available at G3 online.


Articles from G3: Genes|Genomes|Genetics are provided here courtesy of Oxford University Press

RESOURCES